Skip to content
lifestyle.streetregister.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Nutriband Inc.
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
October 13, 2026
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
October 8, 2026
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
October 1, 2026
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America’s Opioid Crisis
September 29, 2026
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O’Neill to Advisory Board
September 25, 2026
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
September 22, 2026
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
September 9, 2026
Nutriband Abuse Deterrent Fentanyl Patch Trademarks Published by USPTO
September 8, 2026
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
August 13, 2026
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
May 24, 2026